Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
暂无分享,去创建一个
Cecilia Jimenez-Mallebrera | Carmen Badosa | D. Cuadras | C. Ortez | C. Jiménez-Mallebrera | Andres Nascimento | Daniel Cuadras | Selena Trifunov | Daniel Natera-de Benito | Jesica Maria Exposito Escudero | Carlos Ortez | Julita Medina | Laura Carrera | D. Natera-de Benito | A. Nascimento | J. Medina | C. Badosa | S. Trifunov | L. Carrera
[1] R. Tsonaka,et al. Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies , 2018, Journal of cachexia, sarcopenia and muscle.
[2] J. Kornegay,et al. Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model , 2013, Current genomics.
[3] K. Bushby,et al. Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy , 2013, PloS one.
[4] S. Pandya,et al. Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1. , 2018, Journal of neuromuscular diseases.
[5] You Li,et al. MiR-206, a Key Modulator of Skeletal Muscle Development and Disease , 2015, International journal of biological sciences.
[6] Juan Li,et al. MicroRNA-206 Downregulation Improves Therapeutic Gene Expression and Motor Function in mdx Mice , 2018, Molecular therapy. Nucleic acids.
[7] Annemieke Aartsma-Rus,et al. Circulating Biomarkers for Duchenne Muscular Dystrophy , 2015, Journal of neuromuscular diseases.
[8] M. Wood,et al. Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases , 2019, EBioMedicine.
[9] I. Pogribny,et al. MicroRNAs as biomarkers for clinical studies , 2018, Experimental biology and medicine.
[10] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[11] Jorge Oliveira,et al. New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy , 2014, Journal of Human Genetics.
[12] M. Wood,et al. Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy. , 2012, Molecular Therapy: Nucleic Acids.
[13] M. Wood,et al. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy. , 2017, Trends in molecular medicine.
[14] Da-Zhi Wang,et al. Regulation of Skeletal Muscle by microRNAs. , 2016, Comprehensive Physiology.
[15] A. Monaco,et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.
[16] Soichiro Kishi,et al. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy , 2014, Environmental Health and Preventive Medicine.
[17] C. Ortez,et al. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy , 2016, Neuromuscular Disorders.
[18] G. van Ommen,et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule , 2006, Muscle & nerve.
[19] M. Mangone,et al. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy , 2019, International journal of molecular sciences.
[20] D. Israeli,et al. Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies , 2016, Scientific Reports.
[21] S. Kalko,et al. Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators , 2015, PloS one.
[22] A. Nakamura,et al. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. , 2008, Cell Structure and Function.
[23] Jay J. Han,et al. The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations , 2010, Muscle & nerve.